Tag:

PanOptica

Latest Headlines

Latest Headlines

Newly-hatched PanOptica lands $30M A round for eye drugs

A fledgling biotech company sustained initially by SV Life Sciences and drawing on some deep ophthalmology expertise has tapped a hefty $30 million Series A round designed to fuel its progress into